Is Oramed Pharmaceuticals, Inc. (ORMP) Stock a Smart Investment Wednesday?

Oramed Pharmaceuticals, Inc. (ORMP) stock is lower by -60.45% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives ORMP stock a score of 33 out of a possible 100.

That rank is chiefly influenced by a short-term technical score of 22. ORMP's rank also includes a long-term technical score of 51.

ORMP has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on ORMP!

See Full ORMP Report

What's Happening with ORMP Stock Today

Oramed Pharmaceuticals, Inc. (ORMP) stock has risen 3.88% while the S&P 500 is higher by 0.47% as of 3:10 PM on Wednesday, Aug 30. ORMP is higher by $0.13 from the previous closing price of $3.22 on volume of 281,277 shares. Over the past year the S&P 500 is up 13.36% while ORMP is lower by -60.45%. ORMP lost -$0.51 per share in the over the last 12 months. Click Here to get the full Stock Report for Oramed Pharmaceuticals, Inc. stock.